<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010037727">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="bold" font="default" size="100%">Luplerdlop, Natthanej</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Missé, Dorothée</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Bray, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Deleuze, V.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Gonzalez, Jean-Paul</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Leardkamolkarn, V.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Yssel, H.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Veas, Francisco</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction</title>
        <secondary-title>Embo Reports</secondary-title>
      </titles>
      <pages>1176-1181</pages>
      <keywords>
        <keyword>endothelial cells</keyword>
        <keyword>haemorrhagic fever viruses</keyword>
        <keyword>matrix metalloprotease inhibitors</keyword>
        <keyword>plasma leakage</keyword>
        <keyword>SB 3CT</keyword>
      </keywords>
      <dates>
        <year>2006</year>
      </dates>
      <call-num>fdi:010037727</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Embo Reports</full-title>
      </periodical>
      <isbn>1469-221X</isbn>
      <accession-num>CC:0002422795-0022</accession-num>
      <number>11</number>
      <electronic-resource-num>10.1038/sj.embor.7400814</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010037727</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2025-01/010037727.pdf</url>
        </pdf-urls>
      </urls>
      <volume>7</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Dengue virus (DV) is an important re-emerging arthropod-borne virus of global significance. The defining characteristic of DV infection-associated pathology is haernorrhagic fever, which often leads to a fatal shock-like syndrome (DHF/DSS) owing to an increase in vascular endothelial permeability. Here, we show, in a viral dose-dependent manner, that DV-infected immature dendritic cells overproduce soluble gelatinolytic matrix metalloproteinase (MMP)-9-and to a lesser extent MMP-2-which enhances enclothelial permeability, but which are reduced by specific inhibitors and a neutralizing anti-MMP-9 antibody. This permeability was associated with a loss of expression of the platelet enclothelial adhesion molecule 1 (PECAM-1) and vascular endothelium (VE)-cadherin cell adhesion molecules and redistribution of F-actin fibres. These in vitro observations were confirmed in an in vivo vascular-leakage mouse model. These results provide a molecular basis for DHF/DSS that could be a basis for a general model of haernorrhagic fever-inducing viruses, and identify a new therapeutic approach for the treatment of viral-induced vascular leakage by specifically targeting gelatinolytic metal loproteases.</abstract>
      <custom6>052</custom6>
    </record>
  </records>
</xml>
